147 related articles for article (PubMed ID: 36006072)
21. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.
Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD
Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765
[TBL] [Abstract][Full Text] [Related]
22.
Zhang J; Jia G; Zuo C; Jia N; Wang H
BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
[TBL] [Abstract][Full Text] [Related]
23. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
Sendler A; Avril N; Helmberger H; Stollfuss J; Weber W; Bengel F; Schwaiger M; Roder JD; Siewert JR
World J Surg; 2000 Sep; 24(9):1121-9. PubMed ID: 11036292
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
Nitzsche EU; Hoegerle S; Mix M; Brink I; Otte A; Moser E; Imdahl A
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):237-42. PubMed ID: 11926386
[TBL] [Abstract][Full Text] [Related]
25. Hypermetabolic lesions of the pancreas on FDG PET/CT.
Dong A; Dong H; Zhang L; Zuo C
Clin Nucl Med; 2013 Sep; 38(9):e354-66. PubMed ID: 23486316
[TBL] [Abstract][Full Text] [Related]
26. Xanthogranulomatous pancreatitis: A review of the imaging characteristics of this rare and often misdiagnosed lesion of the pancreas.
Becker-Weidman D; Floré B; Mortelé KJ
Clin Imaging; 2017; 45():12-17. PubMed ID: 28554050
[TBL] [Abstract][Full Text] [Related]
27. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Zimny M; Schumpelick V
Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284
[TBL] [Abstract][Full Text] [Related]
28. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis.
Kato K; Nihashi T; Ikeda M; Abe S; Iwano S; Itoh S; Shimamoto K; Naganawa S
Clin Nucl Med; 2013 Jun; 38(6):417-21. PubMed ID: 23486318
[TBL] [Abstract][Full Text] [Related]
29. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
Bares R; Klever P; Hauptmann S; Hellwig D; Fass J; Cremerius U; Schumpelick V; Mittermayer C; Büll U
Radiology; 1994 Jul; 192(1):79-86. PubMed ID: 8208970
[TBL] [Abstract][Full Text] [Related]
30. Metastatic embryonal rhabdomyosarcoma to the pancreas presenting as acute pancreatitis detected by FDG PET/CT.
Yang J; Codreanu I; Servaes S; Zhuang H
Clin Nucl Med; 2012 Jul; 37(7):694-6. PubMed ID: 22691517
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT.
Takahashi N; Fletcher JG; Hough DM; Fidler JL; Kawashima A; Mandrekar JN; Chari ST
AJR Am J Roentgenol; 2009 Aug; 193(2):479-84. PubMed ID: 19620446
[TBL] [Abstract][Full Text] [Related]
32. Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review.
Luo Y; Hu G; Ma Y; Guo N; Li F
Medicine (Baltimore); 2017 Sep; 96(38):e7904. PubMed ID: 28930825
[TBL] [Abstract][Full Text] [Related]
33. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
34. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
35. Increased 18F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report.
Ruan M; Liu M; Cheng L; Xie W; Chen L
Medicine (Baltimore); 2016 Sep; 95(36):e4465. PubMed ID: 27603341
[TBL] [Abstract][Full Text] [Related]
36. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
[No Abstract] [Full Text] [Related]
37. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
38. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
39. [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].
Bares R; Dohmen BM; Cremerius U; Fass J; Teusch M; Büll U
Radiologe; 1996 May; 36(5):435-40. PubMed ID: 8778929
[TBL] [Abstract][Full Text] [Related]
40. A fare case of pancreatic metastasis from malignant melanoma mimicking pancreatitis on
Filippi L; Proietti I; Schillaci O; Potenza C; Bagni O
J Egypt Natl Canc Inst; 2021 Oct; 33(1):29. PubMed ID: 34632554
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
